Clinical outcome of embryo cryopreservation in Japanese breast cancer patients: pregnancy rates after transfer of thawed embryos

Okutsu-Horage, Yuki; Iwahata, Hideyuki; Suzuki‐Takahashi, Yuki; Sugisita, Yodo; Takae, Seido; Suzuki, Nao

doi:10.1007/s10815-022-02575-0

“…Cryopreservation is an effective way to preserve fertility and use of preserved tissue frequently results in a successful pregnancy. [12,13] However, the success of the preservation process is highly dependent on the quality of material to be preserved. There is a narrow window of only a few years to undergo preservation of reproductive tissue, especially for eggs, embryos or ovarian tissue.…”

Section: Cryobiology Of Gonadal Tissue Freezingmentioning

confidence: 99%

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Dana,

Assaly

et al. 2023

Preprint

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, ovarian tissue, or embryos. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hindered the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.; fertility; transgender; reproductive technology.

show abstract

“…Cryopreservation is an effective way to preserve fertility and the use of preserved tissue frequently results in a successful pregnancy [12,13]. However, the success of the preservation process depends greatly on the quality of the material to be preserved.…”

Section: Cryobiology Of Gonadal Tissue Freezingmentioning

confidence: 99%

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Ohl,

Assaly

et al. 2023

Uro

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, embryos, or ovarian tissue. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hinders the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.

show abstract

Fertility Preservation Options for Transgender Patients: An Overview

Mainland,

Ohl,

Assaly

et al. 2023

Preprint

0

View full text Add to dashboard Cite

Fertility preservation technologies have existed for decades, and the field is rapidly advancing; limited data exist regarding the use of these technologies by transgender patients. Many options are available for transgender patients who wish to preserve fertility before transitioning. These options include the cryopreservation of gametes, ovarian tissue, or embryos. Currently, ejaculated, or testicular sperm, immature oocytes, and ovarian tissue can be preserved for later use, but no such use option exists for immature testicular tissue. Many financial, sociological, and legal barriers and a lack of awareness among physicians and patients also hindered the utilization of these fertility preservation services. While options are abundant, usage rates are relatively low. The initial data regarding the successful use of preserved tissues appears promising, with birth rates not dissimilar to non-transgender patients. Further investigations into this area are needed. In addition, counseling regarding fertility preservation options should become a significant part of the provider-patient conversation before transitioning therapies.; fertility; transgender; reproductive technology.

show abstract

Clinical outcome of embryo cryopreservation in Japanese breast cancer patients: pregnancy rates after transfer of thawed embryos

Cited by 4 publications

References 23 publications

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Fertility Preservation Options for Transgender Patients: An Overview

Contact Info

Product

Resources

About